CISH and Glucose intolerance: In addition to MAPKs, IL‐1β was shown to enhance the SOCS‐mediated degradation of IRS‐1/2 involving the IkappaB kinase beta (IKKβ)/NF‐κB pathway, promoting glucose intolerance and hepatic insulin resistance by this mechanism.48, 49